Literature DB >> 8979089

TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.

C Geltinger1, K Hörtnagel, A Polack.   

Abstract

In Burkitt's lymphoma (BL) cells the proto-oncogene c-myc is transcriptionally activated by chromosomal translocation to the immunoglobulin (Ig) gene loci. This activation is characterized by preferential transcription from the c-myc promoter P1 and accomplished by juxtaposed Ig enhancer elements. To identify promoter elements required for enhancer-activated P1 transcription, we studied the activation of c-myc reporter gene constructs by the Ig kappa intron and 3' enhancers. Deletion analysis defined the core promoter with a TATA box and two adjacent GC/GT boxes upstream sufficient for basal and enhancer-activated transcription. Gel retardation assays revealed Sp1's binding affinity to the GC/GT box proximal to the TATA box to be higher than to the distal one. This difference correlated well with the resulting levels of transcription mediated by Sp1 in contransfection experiments in BL and Sp1-deficient SL2 cells. Sp3 also bound to the core promoter in vitro, but failed to transactivate in vivo. Mutation of the distal Sp1 site moderately affected basal transcription concomitant with a modest decrease in enhancer stimulation. Mutation of the proximal Sp1 site almost entirely abolished basal as well as enhanced transcription. A considerable level of basal transcription was maintained upon mutation of the TATA box, whereas enhancer-activated transcription largely was abolished. Stable transfection of the BL cell line Raji with constructs containing core promoter mutations confirmed that the proximal Sp1 site and the TATA box are essential for the activation of promoter P1 by the Ig kappa enhancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8979089      PMCID: PMC6148303     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  70 in total

1.  Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes.

Authors:  G Hagen; S Müller; M Beato; G Suske
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 2.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

3.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.

Authors:  E Pascal; R Tjian
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

4.  c-myc expression is activated by the immunoglobulin kappa-enhancers from a distance of at least 30 kb but not by elements located within 50 kb of the unaltered c-myc locus in vivo.

Authors:  J Mautner; U Behrends; K Hörtnagel; M Brielmeier; W Hammerschmidt; L Strobl; G W Bornkamm; A Polack
Journal:  Oncogene       Date:  1996-03-21       Impact factor: 9.867

Review 5.  Transcription elongation and eukaryotic gene regulation.

Authors:  C A Spencer; M Groudine
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

6.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation.

Authors:  G Gill; E Pascal; Z H Tseng; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene.

Authors:  M Takimoto; J P Quinn; A R Farina; L M Staudt; D Levens
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

8.  The role of immunoglobulin kappa elements in c-myc activation.

Authors:  K Hörtnagel; J Mautner; L J Strobl; D A Wolf; B Christoph; C Geltinger; A Polack
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

9.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators.

Authors:  T Hoey; R O Weinzierl; G Gill; J L Chen; B D Dynlacht; R Tjian
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Expression of normal and translocated c-myc alleles in Burkitt's lymphoma cells: evidence for different regulation.

Authors:  D Eick; G W Bornkamm
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  7 in total

1.  Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression.

Authors:  Shibin Ma; Simanta Pathak; Malay Mandal; Long Trinh; Marcus R Clark; Runqing Lu
Journal:  Mol Cell Biol       Date:  2010-06-21       Impact factor: 4.272

2.  Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.

Authors:  N E Wittekindt; K Hörtnagel; C Geltinger; A Polack
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma.

Authors:  Sai-Qun Luo; De-Hui Xiong; Jiang Li; Guangdi Li; Yali Wang; Jia-Ming Zhang; Xiu-Fen Bu; Wei-Xin Hu; Jingping Hu
Journal:  Oncogene       Date:  2020-02-27       Impact factor: 9.867

4.  Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.

Authors:  Isaia Barbieri; Konstantinos Tzelepis; Luca Pandolfini; Junwei Shi; Gonzalo Millán-Zambrano; Samuel C Robson; Demetrios Aspris; Valentina Migliori; Andrew J Bannister; Namshik Han; Etienne De Braekeleer; Hannes Ponstingl; Alan Hendrick; Christopher R Vakoc; George S Vassiliou; Tony Kouzarides
Journal:  Nature       Date:  2017-11-27       Impact factor: 49.962

5.  Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1.

Authors:  Li-Kwan Chang; Jian-Ying Chung; Yi-Ren Hong; Takaya Ichimura; Mitsuyoshi Nakao; Shih-Tung Liu
Journal:  Nucleic Acids Res       Date:  2005-11-28       Impact factor: 16.971

Review 6.  RNA N6-methyladenosine modification in cancers: current status and perspectives.

Authors:  Xiaolan Deng; Rui Su; Hengyou Weng; Huilin Huang; Zejuan Li; Jianjun Chen
Journal:  Cell Res       Date:  2018-04-23       Impact factor: 25.617

Review 7.  Multiple functions of m6A RNA methylation in cancer.

Authors:  Yutian Pan; Pei Ma; Yu Liu; Wei Li; Yongqian Shu
Journal:  J Hematol Oncol       Date:  2018-03-27       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.